Search
for
Sort by
Research 301–330 of 1000+
- Cytochrome P450: A Target for Drug Development for Skin Diseases
- The use of auto-antibody testing in the evaluation of interstitial lung disease (ILD) – A practical approach for the pulmonologist
- The Important Role of Leptin in Modulating the Risk of Dermatological Diseases
- Bioconversion, Pharmacokinetics, and Therapeutic Mechanisms of Ginsenoside Compound K and Its Analogues for Treating Metabolic Diseases
- Tissue Resident Foxp3+ Regulatory T Cells: Sentinels and Saboteurs in Health and Disease
- IGFBP5 Promotes Neuronal Apoptosis in a 6-OHDA-Toxicant Model of Parkinson’s Disease by Inhibiting the Sonic Hedgehog Signaling Pathway
- Construction of the coexpression network involved in the pathogenesis of thyroid eye disease via bioinformatics analysis
- Proteomic analysis identifies differentially expressed proteins participating in forming Type III brush hair in Yangtze River Delta white goat
- Rosmarinus officinalis and Skin: Antioxidant Activity and Possible Therapeutical Role in Cutaneous Diseases
- Understanding human aging and the fundamental cell signaling link in age-related diseases: the middle-aging hypovascularity hypoxia hypothesis
- Editorial: Crosstalk: skin cells and immune cells in inflammatory skin diseases
- Proteomics as a tool to improve novel insights into skin diseases: what we know and where we should be going
- An Insight on Ellagic Acid Formulations for the Management of Skin Diseases
- Hair Manganese as a Marker of Cardiometabolic Status Rather than Coronary Artery Disease Severity—An Exploratory Pilot Study
- Recombinant Filaggrin-2 microneedles reverse androgenetic alopecia by rescuing mitochondrial dysfunction in dermal papilla cells
- Microneedle-Mediated Transdermal Drug Delivery for the Treatment of Multiple Skin Diseases
- Effect of 5-alpha reductase inhibitors in animal models of Parkinson’s disease
- Molecular Morbidity Score–Can MicroRNAs Assess the Burden of Disease?
- Bioinformatic network analysis on the molecular interactions between Parkinson’s disease, alpha-synuclein, and infertility condition
- Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease
- Biological Activities of 2,3,5,4′-Tetrahydroxystilbene-2-O-<i>β</i>-D-Glucoside in Antiaging and Antiaging-Related Disease Treatments
- Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson’s Disease
- Polycystic Ovary Syndrome and the Potential for Nanomaterial-Based Drug Delivery in Therapy of This Disease
- CD169+ Skin Macrophages Function as a Specialized Subpopulation in Promoting Psoriasis-like Skin Disease in Mice
- New Perspectives on Nutraceutical Insulin Sensitizing Agents in the Treatment of Psoriasis and Other Dermatological Diseases
- Mechanisms of Impaired Skeletal Muscle Regeneration and Therapeutic Approaches in Aging and Chronic Disease
- Drug repurposing—a promising approach for patients with angina but non-obstructive coronary artery disease (ANOCA)
- Keratins 6, 16, and 17 in Health and Disease: A Summary of Recent Findings
- The regulation of skin homeostasis, repair and the pathogenesis of skin diseases by spatiotemporal activation of epidermal mTOR signaling
- Cell death in skin function, inflammation, and disease